At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition.

AstraZeneca plc (/ ˌæstrəˈzɛnəkə /) (AZ) is a Swedish-British [3][4][5] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK.

We are a global, science-led, patient-focused biopharmaceutical company, creating innovative medicines for millions of patients worldwide.

We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. AstraZeneca’s US operations are integral to our global business and …

Feb 1, 2026 · AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

AstraZeneca is a British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world.

4 days ago · AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans …

Oct 20, 2025 · AstraZeneca US primarily serves the healthcare sector, providing medications and support services to patients and healthcare providers. It was founded in 1999 and is based in …

Jul 29, 2025 · AstraZeneca has been doubling down on the U.S. market, saying in its second-quarter earnings report on Tuesday that the country was key to its ambition of delivering $80 billion in …

Feb 2, 2026 · AstraZeneca stock AZN +102.96% will start trading on the New York Stock Exchange (NYSE) today, replacing its Nasdaq-listed ADRs. With this move, the company is aiming to attract …